search
Back to results

Closed Incision Negative Pressure Therapy Versus Standard of Care Surgical Dressing in Revision Total Knee Arthroplasty (PROMISES)

Primary Purpose

Surgical Wound, Revision Total Knee Arthroplasty, Wounds and Injuries

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Closed Incision Negative Pressure Therapy (ciNPT)
Standard of Care Dressing
Sponsored by
3M
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Surgical Wound

Eligibility Criteria

22 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Pre-operative Inclusion Criteria:

The subject:

  • is at least 22 years of age on the date of informed consent
  • is able to provide their own informed consent
  • requires a TKA revision defined as one of the following:

    1. a one-stage aseptic revision procedure
    2. a one-stage septic exchange procedure (requiring removal of all hardware) for acute postoperative infection
    3. removal of cement spacer and re-implantation procedure
    4. open reduction and internal fixation of peri-prosthetic fractures
  • has one or more of the following:

    1. a body mass index (BMI) greater than 35 kg/m2
    2. a requirement for the use of blood thinners other than acetylsalicylic acid (ASA) after surgery
    3. history of or current peripheral vascular disease
    4. the presence of lymphedema in the operative limb
    5. insulin-dependent diabetes mellitus
    6. current tobacco use or previous history of smoking and quitting within the past 30 days
    7. a history of prior infection of the operative site
    8. current use of immunomodulators or steroids
    9. current or history of cancer or hematological malignancy (excluding localized skin cancer)
    10. rheumatoid arthritis
    11. current renal failure or dialysis
    12. malnutrition as determined by the investigator
    13. liver disease as determined by the investigator
    14. status post solid organ transplant
    15. HIV
  • is willing and able to return for all scheduled study visits
  • if female, has a negative urine or serum pregnancy test at screening and day of revision surgery. Women who have had surgical sterilization by a medically accepted method such as tubal ligation, hysterectomy, or oophorectomy or are post-menopausal, defined as not having menstruation for >= 12 months will be excluded from requiring this test.

Intra-operative Inclusion Criteria:

The subject:

  • continues to meet all pre-operative inclusion criteria
  • has undergone a TKA revision resulting in a closed surgical incision

Pre-operative Exclusion Criteria:

The subject:

  • is pregnant or lactating
  • will undergo a bilateral TKA within the same operative visit
  • will undergo a bilateral TKA in which the first TKA surgery is on the knee selected for study
  • will undergo a staged bilateral TKA in which the TKA revision surgery for the knee under study occurs within 30 days of the first TKA procedure
  • was previously randomized in this protocol
  • has a systemic active infection at the time of revision not including chronic viral infections such as HIV or hepatitis
  • has a remote-site skin infection at the time of revision
  • was tattooed on the area of the incision within 30 days prior to randomization
  • has known sensitivity to the study product components (drape and/or dressing materials in direct contact with the closed incision or skin)
  • has known sensitivity to silver
  • is currently enrolled in another investigational trial that requires additional interventions
  • is planned to be enrolled in another investigational trial that requires additional interventions at any time during the study
  • has localized skin cancer around the incision site

Intra-operative Exclusion Criteria:

The subject:

  • is found to meet any of the pre-operative exclusion criteria
  • has a surgical incision that precludes placement of dressing
  • has a TKA revision resulting in a muscle flap
  • has a TKA revision resulting in the placement of a spacer
  • has an incision drainage and debridement procedure only
  • has a surgical incision closed with skin glue

Sites / Locations

  • Cleveland Clinic
  • Emory University Orthopedics & Spine Hospital
  • LSU Health Science Center
  • University of Missouri Health Care
  • Northwell Health - SouthSide Hospital
  • New York University (NYU)
  • Hospital for Special Surgery
  • Columbia University Medical Center/New York Presbyterian Hospital
  • Northwell Health - Lenox Hill Hospital
  • Duke University Medical Center
  • Cleveland Clinic
  • Joint Implant Surgeons
  • Oregon Health & Science University
  • University of Pennsylvania
  • Rothman Institute - Thomas Jefferson University Hospital
  • Houston Methodist Research Institute
  • Virginia Commonwealth University

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

Closed Incision Negative Pressure Therapy (ciNPT)

Standard of Care Dressing

Arm Description

Prevena Peel & Place or Prevena Plus Customizable Dressing and ActiVAC Therapy Unit or Prevena Plus Therapy Unit

Silver impregnated dressing

Outcomes

Primary Outcome Measures

Number of Participants With Surgical Site Complications (SSC)
The subject incidence of Investigator-assessed surgical site complications (SSCs) within 90 days of TKA revision. SSCs include any of the following: Superficial Surgical Site Infection (SSI) Deep SSI Full thickness skin dehiscence Seroma or hematoma requiring drainage or surgery Skin necrosis Continued drainage at the time of dressing removal

Secondary Outcome Measures

Number of Participants With Surgical Site Infection (SSI) (Superficial or Deep)
90 day subject incidence of any SSI (superficial or deep)
Number of Participants With Deep Surgical Site Infection
90 day subject incidence of deep surgical site infection

Full Information

First Posted
September 5, 2017
Last Updated
July 29, 2022
Sponsor
3M
search

1. Study Identification

Unique Protocol Identification Number
NCT03274466
Brief Title
Closed Incision Negative Pressure Therapy Versus Standard of Care Surgical Dressing in Revision Total Knee Arthroplasty
Acronym
PROMISES
Official Title
Post-market, Randomized, Open-Label, Multicenter, Study to Evaluate the Effectiveness of Closed Incision Negative Pressure Therapy Versus Standard of Care Dressings in Reducing Surgical Site Complications in Subjects With Revision of a Failed Total Knee Arthroplasty (PROMISES)
Study Type
Interventional

2. Study Status

Record Verification Date
January 2021
Overall Recruitment Status
Completed
Study Start Date
December 5, 2017 (Actual)
Primary Completion Date
November 27, 2019 (Actual)
Study Completion Date
December 19, 2019 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
3M

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
Yes
Product Manufactured in and Exported from the U.S.
No

5. Study Description

Brief Summary
This study evaluates surgical site complications in subjects undergoing revision of a total knee arthroplasty when closed incision negative pressure therapy is used to manage the closed incision, as compared to a standard of care dressing.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Surgical Wound, Revision Total Knee Arthroplasty, Wounds and Injuries, Joint Disease, Musculoskeletal Disease, Prosthesis-Related Infections, Infection, Postoperative Complications, Pathologic Processes

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
294 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Closed Incision Negative Pressure Therapy (ciNPT)
Arm Type
Experimental
Arm Description
Prevena Peel & Place or Prevena Plus Customizable Dressing and ActiVAC Therapy Unit or Prevena Plus Therapy Unit
Arm Title
Standard of Care Dressing
Arm Type
Active Comparator
Arm Description
Silver impregnated dressing
Intervention Type
Device
Intervention Name(s)
Closed Incision Negative Pressure Therapy (ciNPT)
Other Intervention Name(s)
Prevena Peel & Place, Prevena Plus Customizable, ActiV.A.C. Therapy Unit, Prevena Plus 125 Therapy Unit
Intervention Description
Closed Incision Negative Pressure Therapy applied through a foam bolster with a wicking interface fabric that includes 0.019% ionic silver at 125 mmHg of negative pressure for 5-7 days.
Intervention Type
Device
Intervention Name(s)
Standard of Care Dressing
Other Intervention Name(s)
Silver-impregnated dressing, Aquacel Ag Surgical or other equivalent
Intervention Description
A standard silver-impregnated dressing applied to a closed surgical incision for 5-7 days post-operatively.
Primary Outcome Measure Information:
Title
Number of Participants With Surgical Site Complications (SSC)
Description
The subject incidence of Investigator-assessed surgical site complications (SSCs) within 90 days of TKA revision. SSCs include any of the following: Superficial Surgical Site Infection (SSI) Deep SSI Full thickness skin dehiscence Seroma or hematoma requiring drainage or surgery Skin necrosis Continued drainage at the time of dressing removal
Time Frame
within 90 days after TKA revision
Secondary Outcome Measure Information:
Title
Number of Participants With Surgical Site Infection (SSI) (Superficial or Deep)
Description
90 day subject incidence of any SSI (superficial or deep)
Time Frame
90 days after TKA revision
Title
Number of Participants With Deep Surgical Site Infection
Description
90 day subject incidence of deep surgical site infection
Time Frame
90 days after TKA revision
Other Pre-specified Outcome Measures:
Title
Number of Participants With Surgical Site Complication (SSC)
Description
The subject incidence of Investigator-assessed surgical site complications (SSCs) within 90 days of TKA revision. SSCs include any of the the following: Superficial Surgical Site Infection (SSI) Deep SSI Full thickness skin dehiscence Seroma or hematoma requiring drainage or surgery
Time Frame
within 90 days after TKA revision

10. Eligibility

Sex
All
Minimum Age & Unit of Time
22 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Pre-operative Inclusion Criteria: The subject: is at least 22 years of age on the date of informed consent is able to provide their own informed consent requires a TKA revision defined as one of the following: a one-stage aseptic revision procedure a one-stage septic exchange procedure (requiring removal of all hardware) for acute postoperative infection removal of cement spacer and re-implantation procedure open reduction and internal fixation of peri-prosthetic fractures has one or more of the following: a body mass index (BMI) greater than 35 kg/m2 a requirement for the use of blood thinners other than acetylsalicylic acid (ASA) after surgery history of or current peripheral vascular disease the presence of lymphedema in the operative limb insulin-dependent diabetes mellitus current tobacco use or previous history of smoking and quitting within the past 30 days a history of prior infection of the operative site current use of immunomodulators or steroids current or history of cancer or hematological malignancy (excluding localized skin cancer) rheumatoid arthritis current renal failure or dialysis malnutrition as determined by the investigator liver disease as determined by the investigator status post solid organ transplant HIV is willing and able to return for all scheduled study visits if female, has a negative urine or serum pregnancy test at screening and day of revision surgery. Women who have had surgical sterilization by a medically accepted method such as tubal ligation, hysterectomy, or oophorectomy or are post-menopausal, defined as not having menstruation for >= 12 months will be excluded from requiring this test. Intra-operative Inclusion Criteria: The subject: continues to meet all pre-operative inclusion criteria has undergone a TKA revision resulting in a closed surgical incision Pre-operative Exclusion Criteria: The subject: is pregnant or lactating will undergo a bilateral TKA within the same operative visit will undergo a bilateral TKA in which the first TKA surgery is on the knee selected for study will undergo a staged bilateral TKA in which the TKA revision surgery for the knee under study occurs within 30 days of the first TKA procedure was previously randomized in this protocol has a systemic active infection at the time of revision not including chronic viral infections such as HIV or hepatitis has a remote-site skin infection at the time of revision was tattooed on the area of the incision within 30 days prior to randomization has known sensitivity to the study product components (drape and/or dressing materials in direct contact with the closed incision or skin) has known sensitivity to silver is currently enrolled in another investigational trial that requires additional interventions is planned to be enrolled in another investigational trial that requires additional interventions at any time during the study has localized skin cancer around the incision site Intra-operative Exclusion Criteria: The subject: is found to meet any of the pre-operative exclusion criteria has a surgical incision that precludes placement of dressing has a TKA revision resulting in a muscle flap has a TKA revision resulting in the placement of a spacer has an incision drainage and debridement procedure only has a surgical incision closed with skin glue
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Carlos Higuera, MD
Organizational Affiliation
The Cleveland Clinic
Official's Role
Principal Investigator
Facility Information:
Facility Name
Cleveland Clinic
City
Weston
State/Province
Florida
ZIP/Postal Code
33331
Country
United States
Facility Name
Emory University Orthopedics & Spine Hospital
City
Tucker
State/Province
Georgia
ZIP/Postal Code
30084
Country
United States
Facility Name
LSU Health Science Center
City
New Orleans
State/Province
Louisiana
ZIP/Postal Code
70006
Country
United States
Facility Name
University of Missouri Health Care
City
Columbia
State/Province
Missouri
ZIP/Postal Code
65212
Country
United States
Facility Name
Northwell Health - SouthSide Hospital
City
Bay Shore
State/Province
New York
ZIP/Postal Code
11706
Country
United States
Facility Name
New York University (NYU)
City
New York
State/Province
New York
ZIP/Postal Code
10003
Country
United States
Facility Name
Hospital for Special Surgery
City
New York
State/Province
New York
ZIP/Postal Code
10021
Country
United States
Facility Name
Columbia University Medical Center/New York Presbyterian Hospital
City
New York
State/Province
New York
ZIP/Postal Code
10032
Country
United States
Facility Name
Northwell Health - Lenox Hill Hospital
City
New York
State/Province
New York
ZIP/Postal Code
10075
Country
United States
Facility Name
Duke University Medical Center
City
Durham
State/Province
North Carolina
ZIP/Postal Code
27705
Country
United States
Facility Name
Cleveland Clinic
City
Cleveland
State/Province
Ohio
ZIP/Postal Code
44195
Country
United States
Facility Name
Joint Implant Surgeons
City
New Albany
State/Province
Ohio
ZIP/Postal Code
43054
Country
United States
Facility Name
Oregon Health & Science University
City
Portland
State/Province
Oregon
ZIP/Postal Code
97239
Country
United States
Facility Name
University of Pennsylvania
City
Philadelphia
State/Province
Pennsylvania
ZIP/Postal Code
19104
Country
United States
Facility Name
Rothman Institute - Thomas Jefferson University Hospital
City
Philadelphia
State/Province
Pennsylvania
ZIP/Postal Code
19107
Country
United States
Facility Name
Houston Methodist Research Institute
City
Houston
State/Province
Texas
ZIP/Postal Code
77030
Country
United States
Facility Name
Virginia Commonwealth University
City
Richmond
State/Province
Virginia
ZIP/Postal Code
32743
Country
United States

12. IPD Sharing Statement

Learn more about this trial

Closed Incision Negative Pressure Therapy Versus Standard of Care Surgical Dressing in Revision Total Knee Arthroplasty

We'll reach out to this number within 24 hrs